Synchron
About Synchron
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series D T: - FT: Series D |
A: 200000000 MR: - FA: $200 million FAN: 200000000 |
D: 2025-11-06 FD: 2025-11-06 |
12 investors |
Growth Metrics
Team & Leadership
Tom Oxley
CEO and Founder
Martin Dieck
Chairman of the Board
Andy Rasdal
Chief of Staff
Rahul Sharma
Medical Director & Co-Founder
J Mocco
Medical Advisor
Kurt Haggstrom
Chief Commercial Officer
Recent News
Synchron Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- synchron.com
- Industries
- Neurotechnology
- Company Size
- ~480 employees (est.)
- Locations
-
New York City
New York
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro